Monotherapy with a P2Y 12 inhibitor or aspirin for secondary prevention in patients with established atherosclerosis: a systematic review and meta-analysis
- 9 May 2020
- journal article
- review article
- Published by Elsevier BV in The Lancet
- Vol. 395 (10235), 1487-1495
- https://doi.org/10.1016/S0140-6736(20)30315-9
Abstract
No abstract availableFunding Information
- Boston Scientific Corporation
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN 2017N8K7S2)
- Fundación Alfonso Martín Escudero
This publication has 41 references indexed in Scilit:
- High On‐Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)Journal of the American Heart Association, 2012
- Vorapaxar in the Secondary Prevention of Atherothrombotic EventsThe New England Journal of Medicine, 2012
- Antiplatelet effects of aspirin vary with level of P2Y12 receptor blockade supplied by either ticagrelor or prasugrelJournal of Thrombosis and Haemostasis, 2011
- Aspirin has little additional anti‐platelet effect in healthy volunteers receiving prasugrelJournal of Thrombosis and Haemostasis, 2011
- Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health RegistryEuropean Heart Journal, 2009
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Progression of Carotid Stenosis Detected by Duplex Ultrasonography Predicts Adverse Outcomes in Cardiovascular High-Risk PatientsStroke, 2007
- Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialThe Lancet, 2004
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsThe New England Journal of Medicine, 1989